Santos Esteban 4

What Happened

• Santos Esteban, Executive Vice President, Operations at Amgen, disposed of a total of 1,338 shares on May 2, 2026 to satisfy tax and/or exercise-related liabilities. The sales were executed as: 697 shares at $329.82 each ($229,885) and 641 shares at $329.82 each ($211,415), for a combined value of approximately $441,300. These transactions are recorded as payment of exercise price or tax liability (code F), i.e., shares were used/withheld to cover taxes rather than an open-market purchase.

Key Details

• Transaction date: May 2, 2026; Sale prices: $329.82 per share.
• Share counts: 697 shares ($229,885) and 641 shares ($211,415); total 1,338 shares (~$441,300).
• Shares owned after transaction: Not disclosed in the Form 4 filing.
• Footnotes of note:
  • F1: 414 Dividend Equivalents (DEs) were credited to the reporting person's unvested RSUs and paid out in shares on a one-for-one basis per the vesting schedule.
  • F2: Some shares relate to interests acquired under the Company's 401(k) stock fund.
• Filing: Form 4 filed May 5, 2026, reporting the May 2, 2026 transaction; filing does not indicate a late report.

Context

• The transactions are recorded as tax-withholding/exercise-related disposals (code F). Such share dispositions are commonly routine administrative actions to satisfy tax obligations when awards vest or options are exercised and do not necessarily signal a change in the insider’s view of the company.
• Footnote F1 indicates dividend equivalents were converted into shares tied to RSUs; F2 indicates some activity linked to the 401(k) stock fund — both are non-directional, plan-driven events.